BCTX
Briacell Therapeutics
BCTX
BCTX
19 hedge funds and large institutions have $6.38M invested in Briacell Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
14% less funds holding
Funds holding: 22 → 19 (-3)
57% less capital invested
Capital invested by funds: $14.8M → $6.38M (-$8.42M)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
19
Holding in Top 10
1
Calls
$912K
Puts
$224K
Top Buyers
| 1 | +$311K | |
| 2 | +$97.9K | |
| 3 | +$48.9K | |
| 4 |
OBWG
Onyx Bridge Wealth Group
Tarrytown,
New York
|
+$43.3K |
| 5 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$18K |
Top Sellers
| 1 | -$1.56M | |
| 2 | -$302K | |
| 3 | -$144K | |
| 4 |
N
Natixis
Paris,
France
|
-$130K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$73K |